Published in Dtsch Med Wochenschr on July 02, 2004
An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. Biotechniques (1993) 2.10
Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood (1992) 1.81
Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J Virol (1995) 1.72
Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood (1997) 1.59
Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma. Ann Oncol (1991) 1.47
Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies. J Clin Oncol (1994) 1.40
Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia (1997) 1.03
BCL-2 induction is part of the strategy of Epstein-Barr virus. Leuk Lymphoma (1994) 1.00
Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol (1996) 1.00
High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease. Lancet (1992) 0.95
Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy. Proc Natl Acad Sci U S A (1997) 0.95
Immunofluorescent localization of glycogenolytic and glycolytic enzyme proteins and of malate dehydrogenase isozymes in cross-striated skeletal muscle and heart of the rabbit. Histochemistry (1975) 0.94
Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors. Transpl Immunol (1996) 0.94
High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood (1996) 0.92
Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy. Bone Marrow Transplant (1998) 0.92
Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood (2001) 0.92
Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes. Biotechniques (1998) 0.89
Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains. Virology (1976) 0.88
Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Bone Marrow Transplant (1996) 0.87
Turnover of several glycolytic enzymes in rabbit heart, soleus muscle and liver. Hoppe Seylers Z Physiol Chem (1974) 0.87
Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection. J Hematother (1996) 0.86
The inner boundary membrane of mitochondria. Localization and biochemical characterization, possible functions in biogenesis and metabolism. Hoppe Seylers Z Physiol Chem (1974) 0.85
Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases. Heart Surg Forum (2004) 0.84
Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia. Int J Cancer (1986) 0.84
Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab. Ann Hematol (2003) 0.84
A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants. J Natl Cancer Inst (1977) 0.84
Some aspects of regulation of enzyme levels in muscle energy-supplying metabolism. Adv Enzyme Regul (1975) 0.84
Enzyme-linked immunosorbent assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigen. J Immunol Methods (1984) 0.83
In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA. Leukemia (1993) 0.83
Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene. Hum Gene Ther (1997) 0.83
Retrospective comparison of maternal vs. HPA-matched donor platelets for treatment of fetal alloimmune thrombocytopenia. Vox Sang (2009) 0.83
[Extramedullary plasmacytoma]. Dtsch Med Wochenschr (2002) 0.83
Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF alone. Bone Marrow Transplant (2010) 0.83
Serum levels of circulating ICAM-1 are increased in Hodgkin's disease. Leukemia (1993) 0.82
Molecular remission of FLT3-ITD(+) positive AML relapse after allo-SCT by acute GVHD in addition to sorafenib. Bone Marrow Transplant (2011) 0.82
Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study. Ann Hematol (2002) 0.82
Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation. Leuk Lymphoma (1997) 0.81
Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia. Ann Hematol (1992) 0.81
Therapy of invasive aspergillosis with itraconazole: improvement of therapeutic efficacy by early diagnosis. Mycoses (1992) 0.81
Expression of interleukin 10 in B lymphocytes of different origin. Leukemia (1993) 0.81
[Neurotoxicity of 5-fluorouracil]. Dtsch Med Wochenschr (2002) 0.81
Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection. Stem Cells (1996) 0.80
Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation. Bone Marrow Transplant (2000) 0.80
Characterization of the Epstein-Barr virus-induced early polypeptide complex p50/58 EA-D using rabbit antisera, a monoclonal antibody, and human antibodies. Virology (1987) 0.80
Purification of a protein (60K/58K) associated with the Epstein-Barr virus-induced early antigen complex in Raji cells. Int J Cancer (1983) 0.80
[Therapy-resistant cutaneous infiltrates in chronic lymphocytic leukemia]. Hautarzt (2006) 0.79
Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin. Br J Haematol (1998) 0.79
Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment. Bone Marrow Transplant (1996) 0.79
Inhibition of CFU-C growth by VP-16 containing plasma samples obtained from patients after conditioning therapy for bone marrow transplantation. Bone Marrow Transplant (1995) 0.79
Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J Clin Oncol (1993) 0.79
The significance of serum levels of soluble 60kDa receptors for tumor necrosis factor in patients with Hodgkin's disease. Leukemia (1993) 0.79
Intraoperative isolation and processing of BM-derived stem cells. Cytotherapy (2004) 0.78
Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy. Bone Marrow Transplant (1998) 0.78
Transmission of rotavirus diarrhea in a bone marrow transplantation unit by a hospital worker. Bone Marrow Transplant (1991) 0.78
Turnover of malate-dehydrogenase isozymes in rabbit liver and heart. Eur J Biochem (1974) 0.78
Repeated infusions of VWF/FVIII concentrate: impact of VWF:FVIII ratio on FVIII trough and peak levels in a rabbit model. Haemophilia (2011) 0.78
Pharmacokinetics of high-dose VP-16: 6-hour infusion versus 34-hour infusion. Bone Marrow Transplant (1994) 0.78
Nontransferrin-bound iron in serum of patients receiving bone marrow transplants. Free Radic Biol Med (1997) 0.78
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow. Bone Marrow Transplant (1999) 0.78
Disseminated testicular cancer with bulky disease: results of a phase-II study with cisplatin ultra high dose/VP-16/bleomycin. Int J Androl (1987) 0.78
Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation. Br J Haematol (1995) 0.77
Detection of the Epstein-Barr virus-associated antigens EA (early antigen) and VCA (viral capsid antigen) by direct or indirect binding of iodinated antibodies to antigen immobilized in polyacrylamide gel. Eur J Cancer (1979) 0.77
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant (1998) 0.77
No evidence for HTLV infection among leukaemia patients in Germany. Lancet (1984) 0.77
Fibrinogen gamma-chain mRNA is not detected in human megakaryocytes. Blood (1991) 0.77
Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors. Bone Marrow Transplant (1998) 0.76
Translocation t(8;13) in a patient with T cell lymphoma and features of a myeloproliferative syndrome. Leukemia (1995) 0.76
Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAs. FEBS Lett (1994) 0.76
Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis. Bone Marrow Transplant (1996) 0.76
High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study. Ann Oncol (1990) 0.75
Pentoxifylline did not prevent transplant-related toxicity in 31 consecutive allogeneic bone marrow transplant recipients. Blood (1992) 0.75
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease. J Clin Oncol (1997) 0.75
[Gastroenterologic findings in graft versus host disease after allogenic bone marrow transplantation]. Z Gastroenterol (1991) 0.75
[Relationships of enzyme-kinetic properties of cardiac LDH-isoenzymes to cell metabolism]. Verh Dtsch Ges Inn Med (1971) 0.75
Infusion of tumor-contaminated bone marrow for autologous rescue after high-dose therapy leading to long-term remission in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant (1995) 0.75
Increasing the yield of harvested bone marrow cells by raising room temperature during marrow collection. Exp Hematol (1995) 0.75
Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia transplanted with bone marrow from HLA-identical related donors. Blood (1995) 0.75
Immunoglobulin light chains in chronic lymphocytic leukemia and related diseases. Blut (1984) 0.75
Early toxicity of intensified conditioning with etoposide combined with total body irradiation/cyclophosphamide or busulfan/cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantation. Pediatr Hematol Oncol (1996) 0.75
Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results. Ann Hematol (1995) 0.75
Purification of a polypeptide complex (p52) belonging to the D-subspecificites of Epstein-Barr virus-induced early antigens. Virology (1986) 0.75
Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience. Anticancer Res (1997) 0.75
Detection of IgA antibodies to Epstein-Barr virus-associated antigens by ELISA. J Immunol Methods (1984) 0.75
Calcium-related changes of enzyme activities in energy metabolism of cultured embryonic chick myoblasts and myotubes. Eur J Biochem (1975) 0.75
[Current status of the therapy of malignant testicular tumors]. Dtsch Med Wochenschr (1988) 0.75
G-CSF administration following peripheral blood selected CD34-positive cells autologous transplantation accelerates haematological recovery after myeloablative therapy. Br J Haematol (1996) 0.75
Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantation. Ann Hematol (1991) 0.75
Intracerebellar tuberculoma in a patient with AIDS. A case report. Zentralbl Bakteriol (1998) 0.75
Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values. Scand J Infect Dis (1996) 0.75
Factors influencing haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis. A single-centre experience. Support Care Cancer (1997) 0.75
Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides. Infection (1991) 0.75
[Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]. Dtsch Med Wochenschr (1984) 0.75